LBT to trial diabetic foot ulcer prototype
09 August, 2017LBT Innovations, an Australian-listed medical technology company, has signed an agreement with Central Adelaide Local Health Network (CALHN) Vascular and Endovascular Services to use LBT's WoundVue prototype device in a clinical trial.
Targeting the Achilles' heel of breast cancer
04 August, 2017 by Adam FloranceResearchers have found that by combining traditional treatments with a new class of anticancer agents they can target the 'Achilles' heel' of HER2-positive breast cancers, in the first significant improvement in this area in over 30 years.
Blocking the enzyme that helps tumours grow
03 August, 2017Targeting healthy cells that have been hijacked by cancer cells could help treat many different types of the disease, according to scientists from the University of Southampton.
HaemaLogiX signs research agreement with local health institutions
27 July, 2017HaemaLogiX, an Australian immuno-oncology company, has signed an agreement with local health and research institutions for commercialisation rights to an immuno-oncology agent designed to specifically target malignant cancer cells present in the bone marrow of multiple myeloma patients.
Link between high brain iron levels and Alzheimer's
25 July, 2017New research has shown an association between higher levels of brain iron, the presence of Alzheimer's protein amyloid, and poorer memory and language skills.
Prana partners with Takeda to study lead drug
19 July, 2017Prana Biotechnology has formed a research collaboration with Takeda Pharmaceuticals to study the ability of Prana's investigational movement disorders compound, PBT434, to slow or prevent neurodegeneration of the gastrointestinal system.
Oventus receives FDA clearance for O2Vent W
14 July, 2017Australian medical device company Oventus Medical has received FDA 510k clearance for its O2Vent W device.
RMIT research points to treatment breakthrough for viruses
13 July, 2017 by Adam FloranceAn international collaboration headed by RMIT University researchers has discovered a novel new way of treating viral diseases including HIV, dengue, rhinovirus, and influenza, the last of which infects five million people annually with a death rate as high as 10%.
UQ researchers identify protein to control breast cancer progression
13 July, 2017University of Queensland researchers have discovered that switching off a protein produced in breast cancer cells can stop cancer progression.
Optimistic cancer researchers overestimate reproducibility of preclinical studies
05 July, 2017Cancer scientists have been found to overestimate the extent to which high-profile preclinical studies can be successfully replicated, in a study that follows numerous reports exploring biomedicine's so-called reproducibility crisis.
Monash IVF and RHS begin non-invasive PGS trial
29 June, 2017Australian listed companies Monash IVF and RHS (Reproductive Health Science) have partnered to develop an accurate way to test for chromosome number in embryos without biopsy.
Miele expands medical tech business with Steelco stake purchase
29 June, 2017Miele is set to acquire a controlling stake in the Steelco Group to further expand in the medical technology industry.
Coronary artery disease genes influence reproduction
23 June, 2017 by Adam FloranceCoronary artery disease (CAD) is one of the leading causes of death in modern humans and researchers from the University of Melbourne can now explain why.
Medical devices give hope to traditional manufacturers
19 June, 2017 by Caleb RadfordManufacturing companies in Australia are finding niches in the medical technologies sector as their traditional markets of mining and automotive diminish.
Bird flu — the next pandemic?
16 June, 2017 by Adam FloranceSince 2013, nearly 800 people have contracted avian influenza, mostly from poultry markets, but the infection has ended there as it is unable to spread from person to person.
